---
title: "On May 18th, TENCENT spent HKD 501 million to repurchase 1.112 million shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286750081.md"
description: "On May 18, 2026, TENCENT repurchased 1.112 million shares at a cost of HKD 501 million, with a repurchase price per share ranging from HKD 445.8 to HKD 457.4. At the same time, according to the 2023 stock option plan, 8,938 shares were issued"
datetime: "2026-05-18T09:57:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286750081.md)
  - [en](https://longbridge.com/en/news/286750081.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286750081.md)
---

# On May 18th, TENCENT spent HKD 501 million to repurchase 1.112 million shares

According to the announcement from TENCENT (00700), the company repurchased 1.112 million shares for HKD 501 million on May 18, 2026, with a repurchase price per share ranging from HKD 445.8 to HKD 457.4; and issued 8,938 shares upon exercising stock options under the 2023 stock option plan adopted on May 17, 2023

### Related Stocks

- [00700.HK](https://longbridge.com/en/quote/00700.HK.md)
- [TCEHY.US](https://longbridge.com/en/quote/TCEHY.US.md)
- [80700.HK](https://longbridge.com/en/quote/80700.HK.md)
- [HTCD.SG](https://longbridge.com/en/quote/HTCD.SG.md)
- [TCTZF.US](https://longbridge.com/en/quote/TCTZF.US.md)

## Related News & Research

- [DeepSeek could be valued at up to $50 billion in first fundraising, sources say](https://longbridge.com/en/news/285373932.md)
- [China's Impact Therapeutics seeks up to $117 million in Hong Kong IPO, term sheet shows](https://longbridge.com/en/news/285136556.md)
- [China XLX Announces 2026 Q1 Results | CXLFF Stock News](https://longbridge.com/en/news/286673637.md)
- [Transactions in connection with share buyback programme](https://longbridge.com/en/news/286732631.md)
- [JD.com Announces First Quarter 2026 Results | JD Stock News](https://longbridge.com/en/news/286072462.md)